UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024807
Receipt number R000028548
Scientific Title Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults
Date of disclosure of the study information 2016/12/01
Last modified on 2024/01/05 14:15:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults

Acronym

Zouketsushougaihan pure red cell aplasia cohort study (PRCA2016)

Scientific Title

Efficacy and long-term outcome of acquired chronic pure red cell aplasia in adults

Scientific Title:Acronym

Zouketsushougaihan pure red cell aplasia cohort study (PRCA2016)

Region

Japan


Condition

Condition

Acquired chronic pure red cell aplasia

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to establish an optimal management of acquired pure red cell aplasia (PRCA) in adults, the efficacy of immunosuppressive therapy and long-term survival are investigated by employing a cohort longitudinal observational study.

Basic objectives2

Others

Basic objectives -Others

Efficacy of immunosuppressive therapy and the role for iron-chelation therapy in transfusion-dependent patients are also investigated.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Response rate of immunosuppressive therapy, efficacy of iron-chelation therapy in transfusion-dependent patients


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Acquired chronic pure red cell aplasia

Key exclusion criteria

Acute pure red cell aplasia, congenital pure red cell aplasia

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Fumihiro
Middle name
Last name Ishida

Organization

Shinshu University School of Medicine

Division name

Depertment of Biomedical Laboratory Sciences

Zip code

390-0802

Address

3-1-1, Asahi, Matsumoto-shi, Nagano, 390-0802, Japan

TEL

0263-37-2554

Email

fumishi@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Kaoko
Middle name
Last name Sakai

Organization

Shinshu University School of Medicine

Division name

Department of Hematology

Zip code

390-0802

Address

3-1-1, Asahi, Matsumoto-shi, Nagano, 390-0802, Japan

TEL

0263-37-2554

Homepage URL


Email

kaokos@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

Idiopathic Disorders of Haematopoietic Organs Research Committee of the Ministry of Health, Labour and Welfare of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University

Address

3-1-1, Asahi, Matsumoto-shi, Nagano, 390-0802, Japan

Tel

0263-37-2554

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 12 Month 06 Day

Date of IRB


Anticipated trial start date

2016 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not applicable


Management information

Registered date

2016 Year 11 Month 11 Day

Last modified on

2024 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028548


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name